Abstract
Trials in the treatment of the leukemias are sometimes based on a hypothesis, as in the case of exchange transfusion [33] or the use of antimetabolites [86]. Or they are conducted empirically as the results of chance observations, as in the case of the use of the nitrogen mustards, urethane, and the Vinca alkaloids. Or they lie between the two, aiming at making use of well established biological facts: examples are the use of ACTH, cortisone and, more recently, the antibiotics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Bernard, J., Paul, R., Boiron, M., Jacquillat, C., Maral, R. (1969). Introduction. In: Bernard, J., Paul, R., Boiron, M., Jacquillat, C., Maral, R. (eds) Rubidomycin. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88125-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-88125-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-88127-5
Online ISBN: 978-3-642-88125-1
eBook Packages: Springer Book Archive